Skip To Content
  • Search
  • Find My MSL
  • SRL Search
  • Report Adverse Events/Product Complaints
mannkind medical
  • Medical Information
    • SRL Search
    • Submit Medical Inquiry
    • Our Products
  • Clinical Trials
  • Pipeline
  • Publications
  • Congresses
    • Diabetes
    • Cardiorenal
    • Respiratory
Contact Us
  • Search
  • Find My MSL
  • SRL Search
  • Report Adverse Events/Product Complaints
  1. Home
  2. >
  3. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

August 20, 2026

Make a humann connection with us.

MannKind Corporation
Find My MSL SRL Search
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Consumer Health Policy

©2026 MannKind Corporation. All rights reserved.

Welcome to MannKind Medical Affairs

This is a non-promotional website intended for educational purposes. Please confirm your role to continue:

U.S. Caregiver or Patient

Make a humann connection with us.

MannKind Corporation
Find My MSL SRL Search
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Consumer Health Policy

©2026 MannKind Corporation. All rights reserved.